Huijuan Zhu

Xinxiang Medical University — China

Medicine · Health Sciences

27h-index2.3kcitations144works2.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pituitary Gland Disorders and Treatments(36), Growth Hormone and Insulin-like Growth Factors(27), Adrenal and Paraganglionic Tumors(11), Adrenal Hormones and Disorders(11), Cancer-related molecular mechanisms research(8)

Publications142 total

Discovery of Novel CBP/p300 and BRD4 Dual-Target PROTACs with Potent Antitumor Activity in Prostate Cancer
Journal of Medicinal Chemistry·2026
Development of Patient-Derived Conditionally Reprogrammed 3D Breast Cancer Culture Models for Drug Sensitivity Evaluation
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics·2025Open Access
Leptin and leptin resistance in obesity: current evidence, mechanisms and future directions
Endocrine Connections·2025· 3 citedOpen Access
A novel immunoprecipitation-based targeted liquid chromatography-tandem mass spectrometry analysis for accurate determination for copeptin in human serum
Clinical Chemistry and Laboratory Medicine (CCLM)·2025
Improved noninvasive diagnostic evaluations in treatment-naïve adrenocorticotropic hormone (ACTH)-dependent Cushing’s syndrome
BMC Medical Imaging·2025· 2 citedOpen Access
Postoperative Initiation of Thromboprophylaxis in patients with Cushing’s Disease (PIT-CD): a randomized controlled trial
Trials·2025Open Access
Hyperprolactinemia caused by extra-pituitary prolactin secretion: a systematic review
Endocrine Connections·2025· 1 citedOpen Access
Long-term surgical outcomes in TSH-secreting pituitary adenomas: the hidden burden of asymptomatic hyperthyroidism
Endocrine·2025· 5 cited
514 | CAN BASELINE 18F‐FDG PET/CT PREDICT THE PROGNOSIS OF PRIMARY CNS LYMPHOMA?
Hematological Oncology·2025Open Access
697 | NOVEL SMALL MOLECULAR TARGET AGENTS WITH HD‐MTX‐BASED REGIMENS IMPROVED REMISSION RATES WITHOUT PROLONGING PFS IN NEWLY DIAGNOSED PCNSL
Hematological Oncology·2025Open Access
702 | ORAL LENALIDOMIDE OR BTK INHIBITORS AS MAINTENANCE THERAPY SHOWED DURABLE EFFICACY AFTER THE FIRST REMISSION IN PCNSL PATIENTS
Hematological Oncology·2025Open Access
A Novel Weight Loss Mechanism of Hydroxysafflor Yellow A in Obese Mice: Involvement of Immune Inflammation via Prkcd, Btk, and Vav1 Genes in Adipose Tissue
Current Pharmaceutical Biotechnology·2025
Evaluation of an AI facial recognition system for Turner Syndrome screening and facial complexity: a prospective cohort
International Journal of Medical Informatics·2025· 2 cited
A real-world study of lanreotide autogel for the treatment of patients with acromegaly in china: baseline interim analysis
Endocrine Abstracts·2025
The clinicopathological characteristics of co-mutations in exon 2 and 3 of the KRAS gene in patients with colorectal cancer
Pathology - Research and Practice·2025
Correction to “Discovery of Novel 5-Cyano-3-phenylindole-Based LSD1/HDAC Dual Inhibitors for Colorectal Cancer Treatment”
Journal of Medicinal Chemistry·2025
Concurrent TP53 Mutations Facilitate Resistance Evolution in EGFR Exon 20 S768I Mutant Lung Adenocarcinoma: A Case Report and Review of the Literature
Case Reports in Oncology·2025· 2 citedOpen Access
Mof-Driven Α-Fe2o3 with Hollow Microstructures and Oxygen Vacancies for High-Performance Triethylamine Sensing
SSRN Electronic Journal·2025Open Access
Impact of Early Life Famine Exposure on Body Composition and Metabolic Profiles in Adulthood
Maternal and Child Nutrition·2024Open Access
Preparation of Ag-based transparent conductive films with high figure-of-merit from dielectric layers’ combination
Optical and Quantum Electronics·2024· 3 cited
page 1 of 8Next →

Frequent Co-authors

Hui Pan(20), Fengying Gong(16), Hongbo Yang(12), Yong Yao(10), Linjie Wang(10), Renzhi Wang(8), Xinjie Bao(6), Bing Xing(6), Ming Feng(6), Shi Chen(6), Lin Lü(5), Naishi Li(5), Shufeng Chen(4), Bin Yang(4), Dongfeng Gu(4), Shirui Wang(4), Kan Deng(4), Zhouxian Pan(3), Laiyuan Wang(3), Chengsheng Yan(3)